The present invention relates to new formulations containing one or more
estrogens and 2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole compounds
which are useful as estrogenic agents, as well as pharmaceutical
compositions and methods of treatment utilizing these compounds, which
have the general structures below: